Global liver proteomics of rats exposed for 5 days to phenobarbital identifies changes associated with cancer and with CYP metabolism.
A global proteomics approach was applied to model the hepatic response elicited by the toxicologically well-characterized xenobiotic phenobarbital (PB), a prototypical inducer of hepatic xenobiotic metabolizing enzymes and a well-known nongenotoxic liver carcinogen in rats. Differential detergent fractionation two-dimensional liquid chromatography electrospray ionization tandem mass spectrometry and systems biology modeling were used to identify alterations in toxicologically relevant hepatic molecular functions and biological processes in the livers of rats following a 5-day exposure to PB at 80 mg/kg/day or a vehicle control. Of the 3342 proteins identified, expression of 121 (3.6% of the total proteins) was significantly increased and 127 (3.8%) significantly decreased in the PB group compared to controls. The greatest increase was seen for cytochrome P450 (CYP) 2B2 (167-fold). All proteins with statistically significant differences from control were then analyzed using both Gene Ontology (GO) and Ingenuity Pathways Analysis (IPA, 5.0 IPA-Tox) for cellular location, function, network connectivity, and possible disease processes, especially as they relate to CYP-mediated metabolism and nongenotoxic carcinogenesis mechanisms. The GO results suggested that PB's mechanism of nongenotoxic carcinogenesis involves both increased xenobiotic metabolism, especially induction of the 2B subfamily of CYP enzymes, and increased cell cycle activity. Apoptosis, however, also increased, perhaps, as an attempt to counter the rising cancer threat. Of the IPA-mapped proteins, 41 have functions which are procarcinogenic and 14 anticarcinogenic according to the hypothesized nongenotoxic mechanism of imbalance between apoptosis and cellular proliferation. Twenty-two additional IPA nodes can be classified as procarcinogenic by the competing theory of increased metabolism resulting in the formation of reactive oxygen species. Since the systems biology modeling corresponded well to PB effects previously elucidated via more traditional methods, the global proteomic approach is proposed as a new screening methodology that can be incorporated into future toxicological studies.
Dail
Mary B
MB
Center for Environmental Health Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi 39762, USA.
Shack
L Allen
LA
Chambers
Janice E
JE
Burgess
Shane C
SC
D000818:Animals; D002853:Chromatography, Liquid; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D008114:Liver Neoplasms, Experimental / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D010634:Phenobarbital / Q000494:pharmacology*; D040901:Proteomics; D051381:Rats; D017207:Rats, Sprague-Dawley; D021241:Spectrometry, Mass, Electrospray Ionization
D003577:Cytochrome P-450 Enzyme System; D010634:Phenobarbital
BMC Mol Biol. 2007 Apr 12;8:27
17430600
FEBS Lett. 2005 Dec 19;579(30):6733-6
16310787
Cell Death Differ. 2005 May;12(5):512-22
15933726
Proteomics. 2006 May;6(9):2759-71
16596704
J Cell Biol. 1995 Aug;130(3):507-18
7542657
Pharmacol Toxicol. 2001 Sep;89(3):113-22
11589781
FASEB J. 2008 Jan;22(1):74-83
17720800
J Biol Chem. 2007 Sep 21;282(38):28226-36
17644513
Toxicol Sci. 2002 Jun;67(2):232-40
12011482
Nat Methods. 2007 Mar;4(3):207-14
17327847
Electrophoresis. 1994 Feb;15(2):265-77
8026443
Mol Pharmacol. 2002 Jan;61(1):1-6
11752199
Drug Metab Dispos. 2003 Apr;31(4):351-5
12642458
Hepatology. 2002 Jul;36(1):195-201
12085365
Virology. 2007 May 25;362(1):16-25
17257639
J Proteome Res. 2005 Mar-Apr;4(2):316-24
15822906
Plant Physiol. 2007 Aug;144(4):1697-714
17556508
Biochem Biophys Res Commun. 2000 Jan 7;267(1):221-7
10623602
J Biochem Toxicol. 1995 Apr;10(2):63-8
7562954
BMC Genomics. 2006 Sep 08;7:229
16961921
Biochem J. 1992 Feb 1;281 ( Pt 3):577-92
1536639
Exp Cell Res. 2007 Jan 1;313(1):179-94
17112511
Proteomics. 2006 Aug;6(16):4662-70
16897686
Mol Pharmacol. 2007 Dec;72(6):1419-24
17898314
Biochem Biophys Res Commun. 1998 Feb 13;243(2):531-7
9480843
J Cell Sci. 2005 Aug 15;118(Pt 16):3569-72
16105880
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D471-5
15608240
J Biol Chem. 2006 Aug 4;281(31):21878-21883
16762922
Cytogenet Genome Res. 2007;117(1-4):278-87
17675869
Mol Cell Proteomics. 2004 May;3(5):441-55
14739257
Proteomics. 2007 Jul;7(14):2479-88
17623305
Genomics. 2006 Nov;88(5):669-72
16934433
Nucleic Acids Res. 2007 Jan;35(Database issue):D658-62
17151068
Nat Genet. 2000 May;25(1):25-9
10802651
Biochim Biophys Acta. 2003 Feb 17;1619(3):239-42
12573483
Anal Chem. 2002 Nov 1;74(21):5593-9
12433093
Arch Biochem Biophys. 2005 Mar 1;435(1):125-33
15680914
J Biol Chem. 2001 May 25;276(21):17754-61
11278304
Vaccine. 2007 Jan 15;25(5):932-8
17027125
J Biosci Bioeng. 2006 Jun;101(6):501-7
16935252
Cell. 2006 Oct 6;127(1):45-8
17018275
Physiol Genomics. 2001 Apr 27;5(4):161-70
11328961
Mol Cell Biol. 1999 Mar;19(3):1720-30
10022859
J Biol Chem. 1999 Feb 26;274(9):5259-62
10026130
Mol Pharmacol. 2000 Aug;58(2):279-87
10908295
Nature. 1997 Feb 6;385(6616):540-4
9020361
Genomics. 1995 Jul 20;28(2):350-3
8530050
Cell. 2007 Jul 13;130(1):77-88
17632057
Drug Metab Dispos. 2004 Apr;32(4):382-6
15039290
Proteomics. 2007 Apr;7(8):1316-26
17443643
Mol Carcinog. 2006 Dec;45(12):914-33
16921489
Chem Res Toxicol. 2007 Apr;20(4):600-8
17381134
Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1110-5
15650050
Toxicol Sci. 2007 Sep;99(1):35-42
17517822
Toxicology. 2000 Apr 20;146(1):15-22
10773359
Cancer Cell. 2007 Sep;12(3):230-8
17785204
Nat Biotechnol. 1999 Jul;17(7):676-82
10404161
Cell Signal. 2007 May;19(5):892-901
17336499
Mol Reprod Dev. 2006 Jun;73(6):767-73
16541461
Clin Chem. 2005 Oct;51(10):1796-803
16099942
Proteomics. 2005 Dec;5(18):4852-63
16247735
Anal Chem. 2003 Sep 1;75(17):4646-58
14632076
J Biol Chem. 2003 Sep 12;278(37):35184-92
12840027
J Biol Chem. 1999 Dec 10;274(50):35461-8
10585417
J Cell Physiol. 2001 Dec;189(3):334-40
11748591
Genome Biol. 2005;6(1):R9
15642101
FASEB J. 2004 Feb;18(2):379-81
14657004
Toxicol Pathol. 2005;33(1):118-26
15805063
Mutat Res. 2004 May 18;549(1-2):101-13
15120965
BMC Bioinformatics. 2007 Nov 01;8 Suppl 7:S24
18047724
Development. 2002 Apr;129(7):1705-14
11923206
Arch Toxicol. 2004 Aug;78(8):435-42
15107969
Steroids. 2007 Mar;72(3):231-46
17284330
Mutat Res. 2004 Sep 12;563(1):1-11
15324744
Biol Cell. 2004 Aug;96(6):407-11
15384226
Cancer Res. 1999 Jun 15;59(12):2981-8
10383164
Int J Toxicol. 2006 Jan-Feb;25(1):57-64
16510358
Biochem Pharmacol. 2002 Apr 15;63(8):1397-404
11996880
Pharmacol Toxicol. 2002 Jul;91(1):1-7
12193254